The microRNAs hsa_miR-2278 and hsa_miR-6732-3p were identified as potential regulators of RSV transcriptional activity, warranting consideration as novel therapeutic agents.
Computational modeling suggests hsa_miR-2278 and hsa_miR-6732-3p may regulate RSV transcription and could be considered as potential therapeutic agents.
Absolute Event Rate: 0% vs 0%
Globally, RSV is a major contributor to severe lower respiratory tract infections among children. Despite the significant medical concern posed by RSV, efforts to develop effective vaccines and antiviral drugs have largely fallen short, with the exception of immune prophylaxis available only for specific high-risk infants. We employed a suite of computational tools to investigate the role of microRNAs in the host’s response to RSV infection. miRanda and RNAHybrid were instrumental in predicting microRNA-mRNA binding sites. For a deeper structural analysis, MC-Fold and MC-Sym were used to predict the 3D structures of both the miRNAs and their target mRNAs. The interactions between these molecules were then studied through RNA-RNA docking, with the resulting poses evaluated based on binding affinities and interaction profiles. This analysis focused on twelve selected miRNAs and their binding to specific sites on RSV mRNA. Finally, molecular dynamics (MD) simulations were conducted to evaluate the stability of the docked complexes. Taken together, these results suggest that two miRNAs, hsaₘiR-2278 and hsaₘiR-6732-3p, could potentially regulate the transcriptional activity during RSV infection and may warrant consideration as therapeutic agents.
Hassan et al. (Mon,) reported a other. The microRNAs hsa_miR-2278 and hsa_miR-6732-3p were identified as potential regulators of RSV transcriptional activity, warranting consideration as novel therapeutic agents.